Skip to NavigationSkip to content

Penn Pharma starts operations

Published on 09/06/14 at 08:03am
penn pharma image
An API isolator at Penn Pharma

Penn Pharma has opened its expanded facility in South Wales, after a £3 million investment which will allow it to begin large-scale manufacturing there.

The private firm, which delivers integrated drug development, clinical trial supply and manufacturing services to the international healthcare industry, committed last year to spending the extra money.

This was in addition to the £14 million it previously put into expanding the site with a purpose-built contained manufacturing facility which opened last September.

The company’s new suite includes granulation, tableting and coating capabilities, which Penn insists will improve its offering to current and future clients “to service the growing market need for large-scale commercial outsourcing solutions”.

“We continue to grow and invest in new technology and our people,” explains Penn’s chief operating officer Mark Dean-Netscher. “The decision to invest in additional capacity ensures we are able to offer our clients leading-edge technology across all manufacturing areas, continuously improve our service offering and exceed our clients’ expectations by offering the best possible service.”

Based in Tredegar in Blaenau Gwent, the firm last month linked up with France-based BioAlliance to develop and manufacture Validive, a treatment for oral mucositis induced by radiotherapy or chemotherapy in cancer patients.

Penn’s facilities include a Bosch GKF HiProtect combination dose capsule filler, which has been manufacturing capsules since the launch of the new facility in September.

It has a dual dosing station which allows combination capsule products to be manufactured, such as tablets with powders, powders with beads and tablets with tablets.

Penn offers formulation development and analytical services, and support for clinical trial studies by manufacturing and labelling investigational products for distribution to clinical sites worldwide. 

The company also supports the import and release of non-EU products and has specialist facilities for the supply of commercial licensed products including those requiring contained operations.

Adam Hill

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches